CCSVI: another independent study

Study objective: To determine if chronic cerebral venous insufficiency (CCSVI) exists in MS’ers using the criteria proposed by Zamboni.

Study design: MS’ers and people with clinically isolated syndrome were matched by age and sex with subjects with migraine or no neurological disease. 

Main study outcome measures: Five parameters of venous outflow used by Zamboni were examined. 
Results: There was no significant difference in the number and type of venous outflow abnormalities in MS’ers compared with controls.
Conclusion: This study does not support the theory that CCSVI exists in MS.
“Another negative, independent, study makes it unlikely that CCSVI is going to fulfill Bradford-Hill’s criteria for causation or the clinicopathological entity to be considered a diease.”
Other posts on this blog of relevance
15 Apr 2011
CCSVI – time for Sir Bradford-Hill’s criteria for causation. Did you know that there is a whole science behind causation? It started way back in the later 1800’s when Robert Koch formulated his postulates to persuade his 
29 Jul 2011
The scientific framework on which we should be holding this debate is around Bradford-Hill’s criteria for causation. Please see my previous post on this issue: 
28 Jul 2011
Please read post on this blog on the Bradford-Hill criteria of causation and “Bad Science” by Ben Goldacre. Two deaths, two unnecessary deaths, should never have occurred. They unfortunately occurred outside of ethically 

2 thoughts on “CCSVI: another independent study”

  1. This was a study of 18 MS'ers and 11 controls. Nowhere near the scale of the Buffalo study. More info at MSRC site:http://www.msrc.co.uk/index.cfm/fuseaction/show/pageid/2479“Timothy Coetzee, chief research officer at the National Multiple Sclerosis Society, said there are still conflicting opinions about what role CCSVI might play in the disease — and that while this study adds evidence to that debate, it doesn't shut the door on it."In my mind the jury's still somewhat out on what it means for MS," he told Reuters Health.”

Leave a Reply to AnonymousCancel reply

Discover more from Prof G's MS Blog Archive

Subscribe now to keep reading and get access to the full archive.

Continue reading